India’s first indigenously developed RBD protein subunit vaccine, Biological E’s Corbevax, is currently being used to inoculate children in the age group of 12 to...
Continue ReadingThe drug major on the other day said that it has entered into definitive agreements for further investment of Rs 25.90 crore in digital tech...
Continue ReadingThe company has signed definitive agreements with Achira Labs for the purpose, Cipla said in a regulatory filingPharma major Cipla Ltd the other day said...
Continue ReadingWaiver of IP rights will not amount to anything substantial if pharma companies in the Third World do not have the know-how to produce medicines...
Continue ReadingAdditionally, SAP Fiori apps have also helped enhance the user experience for Lupin employees with simple and easy-to-access data models and analytical reports, the company...
Continue ReadingSouth African Health Products Regulatory Authority (SAHPRA) has approved the sweet-tasting, heat-stable and ‘4-in-1’ fixed-dose combination of four antiretroviral (ARV) treatments composed of abacavir, lamivudine,...
Continue ReadingSynopsisAurigene will also be eligible for up to USD 60 million in potential clinical development and regulatory milestones and up to USD 370 million in...
Continue ReadingSuccessful trials for RSV vaccine add much-needed lift to the UK drugmaker’s pipelineGlaxoSmithKline will apply for approval for its respiratory syncytial virus vaccine for older...
Continue ReadingEnsuring uninterrupted supply of medicines to patients and doctors in Sri Lanka is among Sun Pharma’s top priorities. The company has been exploring several alternatives...
Continue Reading